Edwards Lifesciences Corp. (EW)
90.70
+0.20
(+0.23%)
USD |
NYSE |
Aug 25, 14:48
Edwards Lifesciences Cash from Operations (Quarterly) : 651.90M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 651.90M |
| March 31, 2026 | 43.80M |
| December 31, 2025 | 450.90M |
| September 30, 2025 | 573.70M |
| June 30, 2025 | 290.20M |
| March 31, 2025 | 280.40M |
| December 31, 2024 | -127.50M |
| September 30, 2024 | 351.80M |
| June 30, 2024 | 371.50M |
| March 31, 2024 | -53.50M |
| December 31, 2023 | 136.60M |
| September 30, 2023 | 411.50M |
| June 30, 2023 | 33.60M |
| March 31, 2023 | 314.10M |
| December 31, 2022 | 282.80M |
| September 30, 2022 | 309.90M |
| June 30, 2022 | 332.20M |
| March 31, 2022 | 293.30M |
| December 31, 2021 | 373.60M |
| September 30, 2021 | 531.90M |
| June 30, 2021 | 526.10M |
| March 31, 2021 | 300.50M |
| December 31, 2020 | 400.00M |
| September 30, 2020 | 216.10M |
| June 30, 2020 | 231.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 207.00M |
| December 31, 2019 | 399.40M |
| September 30, 2019 | 437.30M |
| June 30, 2019 | 341.20M |
| March 31, 2019 | 1.50M |
| December 31, 2018 | 293.00M |
| September 30, 2018 | 342.30M |
| June 30, 2018 | 140.20M |
| March 31, 2018 | 151.30M |
| December 31, 2017 | 363.90M |
| September 30, 2017 | 310.80M |
| June 30, 2017 | 197.70M |
| March 31, 2017 | 128.30M |
| December 31, 2016 | 201.10M |
| September 30, 2016 | 205.90M |
| June 30, 2016 | 190.30M |
| March 31, 2016 | 107.10M |
| December 31, 2015 | 103.80M |
| September 30, 2015 | 202.50M |
| June 30, 2015 | 170.10M |
| March 31, 2015 | 73.30M |
| December 31, 2014 | 93.20M |
| September 30, 2014 | 12.20M |
| June 30, 2014 | 778.00M |
| March 31, 2014 | 138.90M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Stryker Corp. | 1.261B |
| Intuitive Surgical, Inc. | 1.061B |
| Abbott Laboratories | 2.488B |
| Boston Scientific Corp. | 1.474B |
| Zimmer Biomet Holdings, Inc. | 447.80M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -193.20M |
| Cash from Financing (Quarterly) | -0.30M |
| Free Cash Flow | 1.434B |
| Free Cash Flow Per Share (Quarterly) | 1.013 |
| Free Cash Flow to Equity (Quarterly) | 583.50M |
| Free Cash Flow to Firm (Quarterly) | 585.00M |
| Free Cash Flow Yield | 2.72% |